Viewing Study NCT00028834


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2026-01-25 @ 12:35 AM
Study NCT ID: NCT00028834
Status: COMPLETED
Last Update Posted: 2013-01-24
First Post: 2002-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Pancreas View
None Recurrent Pancreatic Cancer View
None Stage III Pancreatic Cancer View
None Stage IV Pancreatic Cancer View
Keywords: